Bariatric surgery is not a guarantee for weight loss success and patients require holistic postoperative care to prevent weight regain and complications, says a specialist at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.
Portion control plate is a simple tool to help patients balance their meal whereas the food pyramid helps with a balanced diet, says a dietitian at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.
During the recent Malaysian Endocrine and Metabolic Society’s 7th Annual Congress, two teams of endocrinologists gave their take on the motion of ‘A1c target of 7% as expounded by the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) is more pragmatic than the target of 6.5% recommended by the Malaysian CPG for T2DM, AACE and IDF.’
The inclusion of statins in managing chronic kidney disease (CKD) may help reduce patient mortality from stroke and possibly other cardiovascular events, according to an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.
With the number of diets available, it can be confusing for overweight or obese patients to discern which is best for weight loss, says an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.
Patients with hypercholesterolaemia with unchanging LDL-cholesterol levels after 6 weeks of statin treatment should be actively assessed for either statin intolerance or resistance, says an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.
Professor Nor Azmi Kamaruddin, president of Malaysian Endocrine and Metabolic Society, speaks to MIMS Doctor about the state of diabetes in the country and also on the new Clinical Practice Guidelines for the Management of Type 2 Diabetes Mellitus (T2DM)—which was launched in December 2015.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Doctor - Malaysia digital copy today!
A subgroup of patients with HBeAg-negative chronic hepatitis B virus (HBV) infection who ceased their long-term nucleotide analogue treatment maintained virological suppression, pointing to a group of patients who may be suitable for treatment cessation, according to a recent study.
Use of mirabegron in the treatment of men with overactive bladder (OAB) appears to effectively alleviate urgency and storage symptoms, but not reduce the frequency of micturition episodes, according to data from the MIRACLE study.